M&A Deal Summary |
|
---|---|
Date | 2008-03-03 |
Target | QPS |
Sector | Life Science |
Buyer(s) |
Argentum Capital Partners
First Analysis HSBC Capital |
Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Growth Capital Firm |
---|---|
Founded | 1988 |
PE ASSETS | 400M USD |
Size | Middle-Market |
Type | Sector Agnostic |
Argentum Capital Partners is a private equity firm focused on investing in small to mid-sized companies with proven business models and the ability to become market leaders. Prospective transaction situations include growth capital financing, management buyouts, platform acquisitions, and recapitalization. The firm typically takes minority positions, except in the case of management buyouts. Industry sectors of interest include business services, healthcare, and technology. Argentum generally prefers opportunities located in the Eastern US, but will consider companies across the US. Argentum Capital Partners was formed in 1988 and is based in New York City.
DEAL STATS | # |
---|---|
Overall | 16 of 46 |
Sector (Life Science) | 2 of 2 |
Type (Buyout (LBO, MBO, MBI)) | 9 of 10 |
State (Delaware) | 1 of 1 |
Country (United States) | 14 of 43 |
Year (2008) | 2 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2008-02-12 |
ReSearch Pharmaceutical Services
Fort Washington, Pennsylvania, United States ReSearch Pharmaceutical Services, Inc. is a provider of integrated global clinical development solutions to the bio-pharmaceutical industry based on its comprehensive therapeutic expertise, robust clinical operations infrastructure, and highly trained and experienced employee base. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2008-05-29 |
NuCO2
Stuart, Florida, United States NuCo2 is a supplier of liquid carbon dioxide (as opposed to carbon dioxide gas in cylinders) to retail establishments for carbonating and dispensing fountain beverages. It is also the only national supplier to this essentially noncyclical U.S. market. |
Sell | - |
Category | Venture Capital Firm |
---|---|
Founded | 1981 |
PE ASSETS | 800M USD |
Size | Middle-Market |
Type | Sector Agnostic |
First Analysis is a financial advisory and investment firm. First Analysis' private equity arm targets investments in growth companies at all stages of development. The Group looks for opportunities based primarily in the US and can commit up to $10 million of equity per transaction. Sectors of particular interest include outsourced services, (business/government services, education, environmental services, healthcare services, marketing services); information technology, (business integration, call centers, healthcare IT, network security, open source, sensor systems, transaction processing); and chemistry enabled businesses (advanced materials, chemicals, healthcare products, polymers, purification). First Analysis was formed in 1981 and is based in Chicago, Illinois.
DEAL STATS | # |
---|---|
Overall | 27 of 60 |
Sector (Life Science) | 2 of 3 |
Type (Buyout (LBO, MBO, MBI)) | 11 of 11 |
State (Delaware) | 1 of 1 |
Country (United States) | 26 of 57 |
Year (2008) | 4 of 8 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2008-02-12 |
ReSearch Pharmaceutical Services
Fort Washington, Pennsylvania, United States ReSearch Pharmaceutical Services, Inc. is a provider of integrated global clinical development solutions to the bio-pharmaceutical industry based on its comprehensive therapeutic expertise, robust clinical operations infrastructure, and highly trained and experienced employee base. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2008-05-29 |
NuCO2
Stuart, Florida, United States NuCo2 is a supplier of liquid carbon dioxide (as opposed to carbon dioxide gas in cylinders) to retail establishments for carbonating and dispensing fountain beverages. It is also the only national supplier to this essentially noncyclical U.S. market. |
Sell | - |
Category | Private Equity Firm |
---|---|
Founded | 1991 |
PE ASSETS | 1.6B USD |
Size | Large |
Type | Sector Agnostic |
HSBC Capital (North America) the US and Canada principal investments arm of HSBC. HSBC Capital consists of HSBC Capital Canada and HSBC Capital USA. The Group focuses on making private equity and mezzanine investments in profitable, mid-market companies and select real estate transactions. The Group will consider both control and minority positions. Investment proceeds are generally used to support buyouts, expansion financings, recapitalizations, and real estate acquisitions. In addition to targeting US based opportunities, the Group will also consider investments in Latin America. Broad sectors of interest include manufacturing, service, and distribution. HSBC Capital was formed in 1991 and is based in New York City, HSBC Capital has become Graycliff partners on Dec 2011.
DEAL STATS | # |
---|---|
Overall | 20 of 24 |
Sector (Life Science) | 2 of 2 |
Type (Buyout (LBO, MBO, MBI)) | 14 of 17 |
State (Delaware) | 1 of 1 |
Country (United States) | 19 of 23 |
Year (2008) | 1 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2007-12-31 |
Brooks Instrument
Hatfield, Pennsylvania, United States Brooks provides flow measurement and control devices to the low flow application market, and principally serves the chemical and semiconductor industries. |
Buy | $100M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2008-04-01 |
In The Swim
West Chicago, Illinois, United States In The Swim is a multi-channel direct marketer of swimming pool supplies and equipment to the residential and commercial swimming pool markets in the United States. Products include chemicals, covers and liners, equipment, parts, and accessories, which are sold through a catalog, internet, telesales, retail, and wholesale channels. In The Swim was founded in 1982 and is based in West Chicago, Illinois. |
Sell | - |